• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 6/6/24: 3 in 4 Americans Under 65 Concerned About Future of Medicare, The Future of BYOD Adoption & more


The latest news for pharma industry insiders.

The Future of BYOD Adoption

In the third and final part of this video interview, Sam Liu, VP of marketing, Vivalink looks forward in the BYOD space and forecasts potential advancements for consumer devices.

3 in 4 Americans Under 65 Concerned About Future of Medicare

Fears also extend to the future of Social Security, which may run out by 2036, according to the Social Security Office of Retirement and Disability Policy.

Optimizing Remote Monitoring With FSP: Adapting to the New Normal

Discover how integrating FSP remote monitoring into existing workflows can enhance efficiency, collaboration, and success in clinical trials. Gain insights into FSP remote monitoring solutions and real-time data analytics.

OpenAI Insiders Warn of a ‘Reckless’ Race for Dominance

A group of current and former employees is calling for sweeping changes to the artificial intelligence industry, including greater transparency and protections for whistle-blowers.

First FDA-Approved Phase II Stem Cell Treatment Study Shows Significant Improvements in Progressive MS Patients

The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy. The study, which focused on Progressive MS patients, did not meet its primary endpoint but showed improvements in multiple areas – including walking speed, bladder function, and gray matter volume – for patients with significant disability.

MJH Life Sciences on LinkedIn:

🌟 Exciting Opportunity for Biotech Industry Leaders! 🌟

We're thrilled to announce a unique opportunity for visionary CEOs and Executives to participate in our peer-to-peer interview series, Profiles in Medicine, led by our President & CEO, Mike Hennessy Jr.

Join us as we seek insights, challenges, and trends from dynamic associations championing the biotech sector, shaping the life sciences landscape. Mike Hennessy Jr. is deeply committed to advancing healthcare, dedicated to truth and innovation. Your conversation will cover vital topics crucial to industry progress.

Only Pharmaceutical Executive provides the trusted analysis, content, and access that life sciences executives rely on for successful strategies in a rapidly evolving landscape. Don't miss this chance to shape the future of biotech!

Interested in participating? Submit your form here:https://hubs.li/Q02yTFqB0

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs